Trilogy Capital’s Invesco BulletShares 2027 Corporate Bond ETF BSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Buy
246,626
+10,336
+4% +$203K 0.19% 92
2026
Q1
$4.64M Buy
236,290
+8,592
+4% +$169K 0.2% 80
2025
Q4
$4.49M Buy
227,698
+8,973
+4% +$177K 0.2% 80
2025
Q3
$4.31M Sell
218,725
-3,754
-2% -$73.9K 0.2% 76
2025
Q2
$4.37M Sell
222,479
-9,178
-4% -$180K 0.21% 65
2025
Q1
$4.54M Buy
231,657
+8,598
+4% +$168K 0.24% 63
2024
Q4
$4.35M Sell
223,059
-4,755
-2% -$92.9K 0.22% 75
2024
Q3
$4.49M Buy
227,814
+5,672
+3% +$111K 0.23% 76
2024
Q2
$4.27M Sell
222,142
-26,654
-11% -$512K 0.23% 79
2024
Q1
$4.8M Sell
248,796
-15,170
-6% -$293K 0.28% 74
2023
Q4
$5.14M Buy
+263,966
New +$5M 0.32% 64

Other funds holding BSCR

Trilogy Capital's BSCR Position: Q2 2026 in Review

Trilogy Capital increased its Invesco BulletShares 2027 Corporate Bond ETF (BSCR) stake by 4.4% in Q2 2026, buying an estimated $203K and bringing the position to 246,626 shares worth $4.84M. The position accounts for 0.19% of the portfolio, ranked #92.

Trilogy Capital first reported a position in BSCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.14M in Q4 2023. 403 funds tracked by Wall St. Rank hold BSCR as of Q2 2026.

  • Trilogy Capital held 246,626 shares of Invesco BulletShares 2027 Corporate Bond ETF worth $4.84M as of Q2 2026.
  • Trilogy Capital bought 10,336 Invesco BulletShares 2027 Corporate Bond ETF shares in Q2 2026, an estimated $203K.
  • Invesco BulletShares 2027 Corporate Bond ETF made up 0.19% of Trilogy Capital's portfolio in Q2 2026, its #92 holding.
  • Trilogy Capital first reported a position in Invesco BulletShares 2027 Corporate Bond ETF in Q4 2023 and has held it in 11 quarters since.
  • Trilogy Capital's Invesco BulletShares 2027 Corporate Bond ETF position peaked at $5.14M in Q4 2023.
  • 403 funds tracked by Wall St. Rank held Invesco BulletShares 2027 Corporate Bond ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.